州保险覆盖强制令与辅助生殖技术治疗中断的关联
本研究基于美国2016至2018年国家辅助生殖技术监测系统数据,回顾性分析91,324例首次自体辅助生殖技术周期未获活产的患者,发现26.4%中断治疗;与全面覆盖强制令州相比,覆盖不含辅助生殖技术或无强制令州的治疗中断风险分别高46%和26%。
要点
- 首次自体辅助生殖技术周期未获活产后,26.4%患者在12个月内中断治疗。
- 覆盖不含辅助生殖技术或无强制令州的治疗中断风险分别高46%和26%。
- 年龄增加、距诊所≥50英里、既往活产、获卵少及未冻存胚胎与中断率升高相关。
核心结论
- 全面的州强制保险覆盖辅助生殖技术与较低的治疗中断率相关。
研究设计与样本
- 回顾性、基于人群的队列研究,使用2016年和2018年美国向国家辅助生殖技术监测系统报告的生育诊所数据。
- 纳入2016年和2017年开始首次自体辅助生殖技术周期且未获活产的患者,共91,324例。
主要发现
- 91,324例患者中24,072例(26.4%)中断治疗(前次周期失败日期后12个月内无额外周期)。
- 与全面覆盖强制令州相比,覆盖不含辅助生殖技术强制令州的中断调整相对风险为1.46(95%CI 1.31-1.63),无强制令州为1.26(95%CI 1.15-1.39)。
- 患者年龄增加、距诊所≥50英里、既往活产、获卵数较少及未冻存胚胎与较高的中断率相关。
- 无论州强制辅助生殖技术覆盖是否存在或范围如何,非西班牙裔黑人、非西班牙裔亚裔和西班牙裔患者的中断率高于非西班牙裔白人患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Insurance coverage for fertility services may reduce the financial burden of high-cost fertility care such as assisted reproductive technology and improve its utilization. Patients who exit care after failing to reach their reproductive goals report higher rates of mental health problems and a lower sense of well-being. It is important to understand the relationship between state-mandated insurance coverage for fertility services and assisted reproductive technology care discontinuation. OBJECTIVE: This study aimed to assess whether state-mandated insurance coverage for fertility services is associated with lower rates of care discontinuation after an initial assisted reproductive technology cycle that did not result in a live birth. STUDY DESIGN: This is a retrospective, population-based cohort study using data from United States fertility clinics reporting to the National Assisted Reproductive Technology Surveillance System during 2016 and 2018. Patients who began their first autologous assisted reproductive technology cycle during 2016 and 2017 and did not have a live birth were included. We describe the rate of assisted reproductive technology care discontinuation (no additional cycle within 12 months of the previous cycle's date of failure). Multivariable analyses were conducted to evaluate factors independently associated with care discontinuation, including the scope of fertility services included in state coverage mandate at assisted reproductive technology cycle initiation that were as follows: comprehensive (≥3 assisted reproductive technology cycles), limited (1, 2, or an unspecified number of assisted reproductive technology cycles), mandate not including assisted reproductive technology, and no mandate. RESULTS: Among 91,324 patients who underwent their first autologous assisted reproductive technology cycle that did not result in live birth, 24,072 (26.4%) discontinued care. Compared with patients who lived in states with mandates for comprehensive assisted reproductive technology coverage, those in states with mandates for fertility services coverage that did not include assisted reproductive technology or states with no mandate were 46% (adjusted relative risk, 1.46; 95% confidence interval, 1.31-1.63) and 26% (adjusted relative risk, 1.26; 95% confidence interval, 1.15-1.39) more likely to discontinue care, respectively, after controlling for patient and cycle characteristics. Increasing patient age, distance from clinic ≥50 miles, previous live birth, fewer oocytes retrieved, and not having embryos cryopreserved were also associated with higher rates of discontinuation. Non-Hispanic Black, non-Hispanic Asian, and Hispanic patients had higher rates of care discontinuation than non-Hispanic White patients regardless of the existence or scope of state-mandated assisted reproductive technology coverage. CONCLUSION: Comprehensive state-mandated insurance coverage for assisted reproductive technology is associated with lower rates of assisted reproductive technology care discontinuation.
引用
- Lee JC, DeSantis CE, Yartel AK, et al. Association of state insurance coverage mandates with assisted reproductive technology care discontinuation. Am J Obstet Gynecol. 2022. PMID: 36368429. doi:10.1016/j.ajog.2022.10.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。